Orrick Herrington & Sutcliffe advised AXA Investment Managers on the deal. Clifford Chance LLP advised the consortium and Sullivan & Cromwell LLP advised GS Infrastructure. Latham & Watkins advised Antin Infrastructure Partners.
German laboratory group Amedes has been acquired by a consortium that includes Canada’s Omers Infrastructure and Goldman Sachs Asset Management for an undisclosed sum.
The deal could be valued at 1.5 billion euros ($1.8 billion) including debt.
The consortium also includes asset manager AXA Investment Managers, which acted on behalf of its clients.
Amedes operates laboratories at 90 sites in Germany, Belgium, Austria and Dubai, employing about 4,000 staff and treating 450,000 patients a year.
The Orrick team was led by partner Patrick Tardivy (Picture) and included partner Olivier Jouffroy and associate Lara Donnedieu De Vabres for the M&A aspects and partner Patrick Hubert and associate Lena Boucon for the competition law aspects of the transaction.
The international Clifford Chance team advising the investors’ consortium OMERS, Goldman Sachs and AXA was led by partners Anselm Raddatz and Markus Stephanblome with senior associate Tobias Kamerling and associate Denise Rosenau (all Frankfurt/Düsseldorf), further comprising partner Toby Parkinson and senior associate Ed Holmes (both London) as well as senior associate Daniel Gutmann and associate Matthias C. Forster (both Frankfurt/Düsseldorf) (all Corporate); partner Peter Dieners with senior associates Caroline Giesen and Carolin Kemmner as well as associate Marlene Kießling (all Healthcare/Compliance, Düsseldorf); partner Marc Besen with senior associate Johannes Lüer (both Antitrust, Düsseldorf); as well as partner Dominik Engl and counsel Cord von Mandelsloh (both Tax, Frankfurt/Düsseldorf).
A team led by partner Nicholas Kinnersley with senior associate Alim Amershi and associate Raad Gorji (all London) as well as partner Steffen Schellschmidt with senior associate Philip Rosak and associate Peter Gierl (all Frankfurt) (all Global Financial Markets) advised on the transaction financing. The due diligence team comprised partner Ines Keitel, senior associate Susanne Julis and associate Vanessa Zipperich (all Employment, Frankfurt); partner Thomas Reischauer and senior associate Amrei Fuder (both Real Estate, Frankfurt); partner Claudia Milbradt with counsel Susanne Werry, senior associate Nicolas Hohn-Hein and associate Michael Kümmel (all IP, Data Privacy) (all Frankfurt/Düsseldorf); as well as partner Xavier Remy, counsel Gert Cuppens and associate Haaike Wouters (all Corporate, Brussels). Partner Katia Gauzés with senior associate Mélissa Kydem and associate Megi Bllaca (all Corporate, Luxembourg) provided further advice on the transaction structuring.
The Sullivan & Cromwell LLP team included Ben Perry.
Latham & Watkins LLP advised Antin Infrastructure Partners (Antin) on the sale of their majority stake in amedes with a team led by Munich private equity partners Burc Hesse and Sebastian Pauls with associates Chris Freitag, Corinna Freudenmacher and Julia Schöfer. Advice was also provided on corporate/healthcare matters by Hamburg partner Christoph Engeler and associate Philipp Thomssen; on finance matters by Munich partner Thomas Weitkamp and associate Philipp Guggeis; on antitrust matters by Frankfurt partner Max Hauser, Hamburg counsel Jana Dammann de Chapto and Frankfurt associate Alisia Haber; on corporate/IP matters by Frankfurt partner Susan Kempe-Mueller; on regulatory matters by Frankfurt counsel Joachim Grittmann; on tax matters by Munich counsel Ulf Kieker; and on employment matters by Munich associate Kristina Steckermeier.
Involved fees earner: Alim Amershi – Clifford Chance; Marc Besen – Clifford Chance; Megi Bllaca – Clifford Chance; Gert Cuppens – Clifford Chance; Peter Dieners – Clifford Chance; Dominik Engl – Clifford Chance; Matthias Forster – Clifford Chance; Amrei Fuder – Clifford Chance; Katia Gauzès – Clifford Chance; Peter Gierl – Clifford Chance; Caroline Giesen – Clifford Chance; Raad Gorji – Clifford Chance; Daniel Gutmann – Clifford Chance; Nicolas Hohn-Hein – Clifford Chance; Edward Holmes – Clifford Chance; Susanne Julis – Clifford Chance; Tobias Kamerling – Clifford Chance; Ines Keitel – Clifford Chance; Carolin Kemmner – Clifford Chance; Marlene Kießling – Clifford Chance; Nicholas Kinnersley – Clifford Chance; Michael Kümmel – Clifford Chance; Mélissa Kydem – Clifford Chance; Johannes Lüer – Clifford Chance; Claudia Milbradt – Clifford Chance; Toby Parkinson – Clifford Chance; Anselm Raddatz – Clifford Chance; Thomas Reischauer – Clifford Chance; Xavier Remy – Clifford Chance; Philip Rosak – Clifford Chance; Denise Rosenau – Clifford Chance; Steffen Schellschmidt – Clifford Chance; Markus Stephanblome – Clifford Chance; Cord von Mandelsloh – Clifford Chance; Susanne Werry – Clifford Chance; Haaike Wouters – Clifford Chance; Vanessa Zipperich – Clifford Chance; Jana Dammann de Chapto – Latham & Watkins; Christoph Engeler – Latham & Watkins; Chris Freitag – Latham & Watkins; Corinna Freudenmacher – Latham & Watkins; Joachim Grittmann – Latham & Watkins; Philipp Guggeis – Latham & Watkins; Alisia Maria Haber – Latham & Watkins; Sebastian Max Hauser – Latham & Watkins; Burc Hesse – Latham & Watkins; Susan Kempe-Mueller – Latham & Watkins; Ulf Kieker – Latham & Watkins; Sebastian Pauls – Latham & Watkins; Julia Schöfer – Latham & Watkins; Kristina Steckermeier – Latham & Watkins; Philipp Thomssen – Latham & Watkins; Thomas Weitkamp – Latham & Watkins; Lena Boucon – Orrick Herrington & Sutcliffe LLP; Lara Donnedieu de Vabres – Orrick Herrington & Sutcliffe LLP; Patrick Hubert – Orrick Herrington & Sutcliffe LLP; Olivier Jouffroy – Orrick Herrington & Sutcliffe LLP; Patrick Tardivy – Orrick Herrington & Sutcliffe LLP; Ben Perry – Sullivan & Cromwell;